Article info
PDFClinical pharmacy
CP-101 Natalizumab every 6 weeks versus standard dose: evaluation of effectiveness. preliminary study
Citation
CP-101 Natalizumab every 6 weeks versus standard dose: evaluation of effectiveness. preliminary study
Publication history
- First published February 25, 2017.
Online issue publication
February 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions